20
Aarti Pharmalabs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
One of their notable products is MOMETASONE FUROATE USP (ALTERNATE PROCESS), with a corresponding US DMF Number 33174.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2018, highlighting commitment to regulatory compliance.